京都大学 / 新制・論文博士 / 博士(医学) / 乙第13566号 / 論医博第2293号 / 新制||医||1068(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 柊, 卓志, 教授 篠原, 隆司, 教授 後藤, 慎平 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

No description available.

Plants have molecular mechanisms for nutrient-related stress responses; however, their exact regulation remains unclear. For example, the integral myo-inositol (inositol) signal transduction pathway allows Arabidopsis thaliana to sense and respond to changes in environmental stimuli, such as water, light availability, and nutrient stress. The inositol signaling pathway relies on dynamic changes in second messenger levels of inositol(1,4,5)P3 (InsP3) and is regulated by myo-inositol polyphosphate 5-phosphatases (5PTases). The 5PTses keep balance between InsP3 signal transduction and termination. Previous work has identified the Sucrose non-fermenting (Snf) 1-related kinase (SnRK1.1) as a binding partner to 5PTase13, a potential InsP3 regulator, and a novel protein called P80, a predicted component of the Cullin4 (CUL4) E3 Ubiquitin ligase complex. In plants, SnRK1.1 is a central integrator of metabolism, stress responses, and developmental signals. Moreover, SnRK1.1 is conserved with the eukaryotic AMP-activated protein (AMPK) and Snf1 kinases—enzymes fundamental to transcriptional regulation and metabolic balance. Studying SnRK1.1 regulation may reveal mechanisms for agricultural sustainability and may offer valuable links to understanding metabolic diseases and lifespan in humans. Therefore, the research presented here centered on characterizing the regulation of SnRK1 gene expression and steady-state protein levels in plants. I show developmental and nutrient-related regulation of spatial expression patterns of SnRK1 genes and SnRK1.1 protein. Further, I present a model for regulation of SnRK1.1 protein stability in vivo based on SnRK1.1 steady-state protein levels in p80 and cul4 co-suppressed (cs) mutants. My results indicate SnRK1.1 regulation is dynamic, and dependent on the timing of particular cues from development and the environment. / Master of Science

The cells from the inner cell mass (ICM) of an early embryo have the potential to differentiate into all the different cell types present in an adult organism. Cells from the ICM can be isolated and cultured in vitro, becoming embryonic stem cells (ESCs). ESCs have several properties that make them unique: they are unspecialized, can self-renew indefinitely in culture, and given the appropriate cues can differentiate into cells from all three germ layers (ecto-, meso-, and endoderm), including the germline, both in vivo and in vitro. Induced pluripotent stem cells (iPSCs) can be generated from adult, terminally differentiated somatic cells by transient exogenous expression of four transcription factors (Oct4, Sox2, Klf4, and cMyc; OSKM) present normally in ESCs. It has been shown that iPSCs are equivalent to ESCs in terms of morphology, gene expression, epigenetic signatures, in vitro proliferation capacity, and in vitro and in vivo differentiation potential. However, unlike ESCs, iPSCs can be obtained from a specific individual without the need for embryos. This makes them a promising source of pluripotent cells for regenerative medicine, tissue engineering, drug discovery, and disease modelling; additionally, in livestock species such as the bovine, they also have applications in genetic selection, production of transgenic animals for agricultural and biomedical purposes, and species conservancy. Nevertheless, ESC and iPSC lines that meet all pluripotency criteria have, to date, only been successfully produced in mice, rats, humans, and non-human primates. In the first part of this dissertation, we attempted reprogramming of three types of bovine somatic cells: fetal fibroblasts (bFFs), adult fibroblasts (bAFs), and bone marrow-derived mesenchymal stem cells (bMSCs), using six different culture conditions adapted from recent work in mice and humans. Using basic mouse reprogramming conditions, we did not succeed in inducing formation of ESC-like colonies in bovine somatic cells. The combination of 2i/LIF plus ALK5 inhibitor II and ascorbic acid, induced formation of colony-like structures with flat morphology, that occasionally produced trophoblast-like structures. These trophoblast-like vesicles did not appear when an inhibitor of Rho-associated, coiled-coil containing protein kinase 1 (ROCK) was included in the medium. We screened for expression of exogenous OSKM vector with RT-PCR and found upregulation of OSKM vector 24h after Dox was added to the medium; however, expression was sharply decreased on day 2 after Dox induction, and was not detectable after day 3. In a separate experiment, we induced reprogramming of bFF and bAFs using medium supplemented with 50% of medium conditioned by co-culture with the bovine trophoblast CT1 line. These cells expressed both OCT4 and the OSKM vector 24h after Dox induction. However, similar to our previous observations, both markers decreased expression until no signal was detected after day 3. In summary, we were unable to produce fully reprogrammed bovine iPSCs using mouse and human protocols, and the exact cause of our lack of success is unclear. It is possible that a different method of transgene expression could play a role in reprogramming. However, these ideas would be driven by a rather empirical reasoning, extrapolating findings from other species, and not contributing in our understanding of the particular differences of pluripotecy in ungulates. Our inability to produce bovine iPSCs, combined with the only partial reprogramming observed by others, justifies the need for in depth study of bovine pluripotency mechanisms, before meaningful attempts to reprogram bovine somatic cells to plutipotency are made. Therefore, we focused on getting a better understanding of bovine nuclear reprogramming. This would allow us to rationally target the specific requirements of potential bovine pluripotent cells. Cell fusion is a process that involves fusion of the membrane of two or more cells to form a multinucleated cell. Fusion of a somatic cell to an ESC is known to induce expression of pluripotency markers in the somatic nucleus. In the second part of this dissertation, we hypothesized that fusion of bFFs to mouse ESCs (mESCs) would induce expression of pluripotency markers in the bFF nucleus. We first optimized a cell fusion protocol based on the use of polyethylene glycol (PEG), and obtained up to 11.02% of multinucleated cells in bFFs. Next, we established a method to specifically select for multinucleated cells originated from the fusion of mESCs with bFFs (heterokaryons), using indirect immunofluorescence. With this in place, flow cytometry was used to select 200 heterokaryons which were further analyzed using RNA-seq. We found changes in bovine gene expression patterns between bFFs and heterokaryons obtained 24h after fusion. Focusing on the bovine transcriptome, heterokaryons presented upregulation of early pluripotency markers OCT4 and KLF4, as well as hypoxia response genes, contrasted with downregulation of cell cycle inhibitors such as SST. The cytokine IL6, known to increase survival of early embryos in vitro, was upregulated in heterokaryons, although its role and mechanism of action is still unclear. This indicates that the heterokaryon cell fusion model recapitulates several of the events of early reprogramming, and can therefore be used for further study of pluripotency in the bovine. The cell fusion model presented here can be used as a tool to characterize early changes in bovine somatic nuclear reprogramming, and to study the effect of different reprogramming conditions on the bovine transcriptome. / Ph. D. / The cells of an early embryo have the potential to give rise to any cell type found in the adult body. When these cells are transferred to a culture dish and kept under the right conditions, they become Embryonic Stem Cells (ESCs), and they retain the same developmental potential as the original embryonic cells they were derived from. In 2006, researchers in Japan found that it is possible to “reprogram” the cells of an adult individual (for example, fibroblast skin cells taken from a biopsy) to an embryonic state, by forcing the cells to express extra copies of genes that are normally active in embryos. These reprogrammed cells are called induced Pluripotent Stem Cells (iPSCs), and similarly to ESCs, they also have the potential to produce any cell type found in an adult organism. Lines of iPSCs from livestock species have possible applications in agriculture, species conservancy, biomedical industry, and veterinary and human health. Unfortunately, for reasons that are to date not fully understood, the technology to produce iPSCs has, so far, only worked in mice, rats, humans, and non-human primates. We first attempted to produce bovine iPSCs by adapting methods and conditions used to derive iPSCs in mice and humans. We observed partial reprogramming of bovine cells, but were ultimately not able to produce true bovine iPSCs. This suggests that the bovine requires alternative/additional factors to induce reprogramming in adult cells. However, not knowing exactly what conditions or reagents will induce the reprogramming process in the cow, we decided to take a different approach. We focused on trying to understand how nuclear reprogramming works in the bovine. This would allow us to rationally target the specific requirements of potential bovine pluripotent cells. It is known that the fusion (“merging”) of an adult cell with a stem cell, causes the adult cell to change its gene expression pattern to resemble a stem cell. We therefore fused mouse ESCs with bovine fibroblasts, and observed changes in bovine gene expression pattern as early as 24 hours after fusion. The gene expression changes observed resemble those found during early reprogramming of human and mouse iPSCs, and are accompanied by silencing of fibroblast specific genes. This suggests that our cell fusion model recreates the changes that happen during reprogramming, and can therefore be used as a tool to better understand pluripotency in the cow. The cell fusion method described in this dissertation can in theory be adapted to other species; by fusing somatic cells from other species to mouse ESCs, this model can be used to find species specific relevant pluripotency genes.

Der Gen-Knockdown mittels RNAi hat sich als essentiell erwiesen, um Inhibitoren der induzierten Transdifferenzierung in C. elegans zu identifizieren (Tursun et al., 2011). Bakterienstämme, die dsRNA exprimieren, das die Expression spezifischer Gene mindert, können dem Wurm direkt zugefüttert werden, um einen genomweiten RNAi-screen der insgesamt 20.000 Gene in C. elegans durchzuführen. Allerdings werden die meisten biologischen Prozese durch mehr als ein Gen reguliert, was den Bedarf nach einer Methode generiert, die es erlaubt, zwei oder mehr Gene gleichzeitig herunter zu regulieren, um die Steuerung biologischer Prozesse studieren zu können. Die derzeitig vorhandenen Methoden liefern entweder nicht reproduzierbare Ergebnisse oder sind nicht skalierbar. Wir nutzen baktierelle Konjugation, die es durch ein konjugatives Plasmid ermöglicht Bakterienzellen zu generieren, die zwei verschiedene RNAi-Plasmide enthalten. Das Ziel war es, modifizierte RNAi-Donor-Plasmide mittels bakterieller Konjugation an eine Vielzahl anderer Bakterienzellen zu übertragen, die bereits ein anderes RNAi-Plasmid enthalten und dies dann im Hochdurchsatzverfahren durchführen zu können. Um Enhancer induzierter Expression von unc-25::gfp in der Keimbahn, ermöglicht durch den Knockdown des Histonchaperons LIN-53 (RbAp46/48 in Menschen), zu finden, wurden RNAi-Klone generiert, die gleichzeitig lin-53 als auch eines von insgesamt 800 verschiedenen Chromatin-bezogenen Gene herunter regulieren. Dabei identifizierten wir RBBP-5, Mitglied des Set1/ MLL-Methyltransferase-Komplexes, als neuen Barrierefaktor der induzierten Transdifferenzierung. RBBP-5 agiert dabei mutmaßlich parallel zu LIN-53. Doppelte RNAi, ermöglicht durch bakterielle Konjugation, erlaubt den simultanen Knockdown zweier oder mehr Gene, um genetische Interaktionen studieren zu können und erweitert damit die Einsatzmöglichkeiten von RNAi-Screens, um untereinander verbundene biologische Prozesse zu studieren. / The knock down of genes by RNAi has been fundamental to identify inhibitors of induced cell transdifferentiation in C. elegans (Tursun et al., 2011). Bacteria strains expressing dsRNA that target specific genes can be fed to the worm allowing straightforward whole-genome RNAi screens of the 20,000 genes in theC. elegans genome. However, many biological processes are regulated by more than one gene raising the need for simultaneous knock down of two or more genes to more fully interrogate the regulation of complex biological processes. Two approaches are currently available for double RNAi knockdown, − two bacteria strains expressing specific dsRNA can be mixed and grown together and fed simultaneously, which gives highly variable results. Alternatively, a new bacterial clone can be generated carrying a plasmid on which two RNAi targets of interest are 'stitched' together, which is not scalable. To address this challenge, we have developed a protocol using bacterial conjugation mediated by the 'Fertility Factor' (F) Episome in order to combine two different RNAi plasmids in a single bacterium. The objective was to be able to transfer a single RNAi plasmid to a large number of bacterial cells carrying different RNAi clones in one step in a high-throughput manner for large scale 'double' or even 'triple' RNAi screens. To find enhancers of induced unc-25::gfp expression in the germ line enabled by the depletion of histone chaperone LIN-53 (RbAp46/48 in humans), double RNAi clones targeting lin-53 and a total of 800 chromatin-related genes were generated and screened. We identified the Set1/MLL methyltransferase complex member RBBP-5 as a novel reprogramming barrier that putatively acts in a parallel pathway to LIN-53. Double RNAi by conjugation permits to reliably knock down two genes simultaneously in order to study genetic interactions at a genome-wide level, thus further increasing the versatility of RNAi screens to investigate interconnected biological processes.

The emergence of the Internet of Things (IoT) has increased the demand for networked, resource-constrained devices tremendously. Many of the devices used for IoT applications are designed to be resource-constrained, as they typically must be small, inexpensive, and powered by batteries. In this dissertation, we consider a number of challenges pertaining to these constraints: system support for energy efficiency; flash-based storage systems; programming, testing, and debugging; and safe and secure application execution. The contributions of this dissertation are made through five research papers addressing these challenges. Firstly, to enhance the system support for energy-efficient storage in resource-constrained devices, we present the design, implementation, and evaluation of the Coffee file system and the Antelope DBMS. Coffee provides a sequential write throughput that is over 92% of the attainable flash driver throughput, and has a constant memory footprint for open files. Antelope is the first full-fledged relational DBMS for sensor networks, and it provides two novel indexing algorithms to enable fast and energy-efficient database queries. Secondly, we contribute a framework that extends the functionality and increases the performance of sensornet checkpointing, a debugging and testing technique. Furthermore, we evaluate how different data compression algorithms can be used to decrease the energy consumption and data dissemination time when reprogramming sensor networks. Lastly, we present Velox, a virtual machine for IoT applications. Velox can enforce application-specific resource policies. Through its policy framework and its support for high-level programming languages, Velox helps to secure IoT applications. Our experiments show that Velox monitors applications' resource usage and enforces policies with an energy overhead below 3%. The experimental systems research conducted in this dissertation has had a substantial impact both in the academic community and the open-source software community. Several of the produced software systems and components are included in Contiki, one of the premier open-source operating systems for the IoT and sensor networks, and they are being used both in research projects and commercial products.

Mitochondrial diseases encompass a broad range of devastating disorders that typically affect tissues with high-energy requirements. These disorders have been difficult to diagnose and research because of the complexity of mitochondrial genetics, and the large variability seen among patient populations. We have devised and carried out a mechanistic study to generate a cell based model for Leigh’s disease caused by mitochondrial DNA mutation 8993 T>G. Leigh’s disease is a multi-organ system disorder that depends heavily on the mutation burden seen within various tissues. Using new reprogramming and sequencing technologies, we were able to show that Leigh’s disease patient fibroblasts reprogrammed to induced pluripotent stem cells maintain the same level of mutation burden seen in the original patient cell line. Mutation burden was maintained through several passages and spontaneous differentiation. This cell based model could be useful for future pathogenesis studies, or therapeutic drug screenings in a patient and tissue specific manner.

Lors de la fécondation, le génome subit des transformations épigénétiques qui vont guider le développement et le phénotype de l’embryon. L'avènement des techniques de reprogrammation cellulaire, permettant la dédifférenciation d'une cellule somatique adulte, ouvre la porte à de nouvelles thérapies régénératives. Par exemple, les procédures de transfert nucléaire de cellules somatique (SCNT) ainsi que la pluripotence par induction (IP) visent à reprogrammer une cellule somatique adulte différentiée à un état pluripotent similaire à celui trouvé durant la fécondation chez l'embryon sans en impacter l'expression génique vitale au fonctionnement cellulaire. Cependant, la reprogrammation partielle est souvent associée à une mauvaise méthylation de séquences géniques responsables de la régulation des empreintes géniques. Ces gènes, étudiés chez la souris, le bovin et l'humain, sont exprimés de manière monoallélique, parent spécifique et sont vitaux pour le développement embryonnaire. Ainsi, nous avons voulu définir le statut épigénétique du gène empreinté H19 chez l'équin, autant chez le gamètes que les embryons dérivés de manière in vivo, SCNT ainsi que les cellules pluripotentes induites (iPSC). Une région contrôle empreinté (ICR) riche en îlots CpG a été observée en amont du promoteur. Couplé avec une analyse de transcrit parent spécifique du gène H19, nous avons confirmé que l'empreinte du gène H19 suit le modèle insulaire décrit chez les autres mammifères étudiés et résiste à la reprogrammation induite par SCNT ou IP. La déméthylation partielle de l'ICR observée chez certains échantillons reprogrammés n'était pas suffisante pour induire une expression biallélique, suggérant un contrôle des empreintes chez les équins durant la reprogrammation. / After fertilization, the animal genome undergoes a complex epigenetic remodeling that dictates the growth and phenotypic signature of the animal. The development of reprogramming methods using adult differentiated cells as the primordial genetic source has opened the door to new regenerative therapies for animals. Somatic cell nuclear transfer (SCNT) and induced pluripotency are two techniques which aim to reprogram a cell from its adult differentiated state to an embryonic-like pluripotency level, without impairing the expression of genes vital for the cellular function. Albeit promising, the mechanisms involved in these techniques remain only moderately understood. Partial reprogramming is frequently associated with irregular methylation of DNA sequences responsible for imprint regulation. These imprinted genes, mostly studied in rodents, cattle and humans, are expressed in a monoallelic parent-specific fashion and are vital for embryo growth. Hence, we aim to define the equine H19 imprinting control region (ICR) in gametes, in vivo and in SCNT derived embryos, as well as in induced pluripotent stem cells (iPSC). A CpG rich ICR was characterized upstream of the promotor using bisulfite treated DNA sequencing. Coupled with parent-specific gene expression analysis, we confirmed that the imprinted gene H19 is resistant to cellular reprogramming, and that partial demethylation of its ICR does not result in biallelic expression, suggesting that equine species have rigorous imprint maintenance during cellular reprogramming.

O Adenocarcinoma ductal pancreático (ADP) é o tumor pancreático mais comum e apresenta um dos piores prognósticos. A primeira alteração crítica que desencadeia o processo de progressão tumoral, é a ativação desregulada do gene KRAS, na qual está presente em 90% dos casos. Várias iniciativas terapêuticas buscaram como alvo direto a atividade da oncoproteína RAS, sem no entanto, obter resultados satisfatórios. Desta forma, a investigação de moléculas efetoras downstream às vias reguladas por RAS, poderiam resultar em estratégias mais eficazes. Dentre estas moléculas efetoras estão as MAPKs, que modulam diversos processos celulares essenciais para o desenvolvimento tumoral, onde a cascata RAS/RAF/MEK/ERK representa uma importante via canônica de transdução de sinais. A transdução de sinais desta via pode ser favorecida por proteínas conhecidas como proteínas de arcabouço, como SHOC2, funcionando como uma plataforma para ligação de RAS-RAF-1 e consequentemente potencializando sua ligação. KRAS, têm sido associado à regulação de vias metabólicas importantes, como a glicólise que interferem diretamente na capacidade de proliferação e sobrevivência celular, para o estabelecimento e manutenção da biologia tumoral. Assim, o objetivo deste trabalho foi investigar o papel da proteína SHOC2 na indução do estresse oxidativo e capacidade de sobrevivência de linhagens celulares de ADP. Foram realizados os ensaios de morte celular por apoptose, avaliação da capacidade clonogênica e quantificação dos níveis de glutationa e quantificação da produção de espécies reativas de oxigênio. As linhagens celulares MIA PaCa2 e PANC-1 apresentaram uma redução significativa da capacidade de formação de colônias. A taxa de apoptose induzida pelo tratamento com Gemcitabina não diferiu entre as linhagens modificadas para silenciar a função de SHOC2. No ensaio da quantificação dos níveis de glutationa e na produção de espécies reativas de oxigênio, os resultados não foram concordantes com o esperado. Para análise dos níveis proteicos de p-ERK1/2, podemos observar uma redução na sua expressão, mesmo se mostrando de maneira sutil. Os resultados sugerem que pode haver alguma relação entre o silenciamento de SHOC2, estresse oxidativo e sobrevivência, porém existem outras vias alternativas modulando este processo. / Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic tumor and has one of the worst prognoses. The first critical change that triggers the process of tumor progression is the dysregulated activation of the KRAS gene, in which it is present in 90% of cases. Several therapeutic initiatives aimed directly at the activity of the RAS oncoprotein, without, however, obtaining satisfactory results. Thus, investigating downstream effector molecules on RAS-regulated pathways could result in more effective strategies. Among these effector molecules are MAPKs, which modulate several cellular processes essential for tumor development, where the RAS / RAF / MEK / ERK cascade represents an important canonical pathway for signal transduction. Signal transduction of this pathway may be favored by proteins known as scaffold proteins, such as SHOC2, serving as a platform for RAS-RAF-1 binding and hence potentiating its interaction. KRAS, have been associated with the regulation of important metabolic pathways, such as glycolysis, for the establishment and maintenance of tumor biology. Thus, the objective of this work was to investigate the role of SHOC2 in the induction of oxidative stress and survival capacity of ADP cell lines. Cell death assays were performed by apoptosis, and quantification of glutathione levels and the production of reactive oxygen species were performed. MIA PaCa2 and PANC-1 cell lines showed a reduction in colony formation capacity. Gemcitabine-mediated cell death by apoptosis has not been induced after SHOC2 knockdown. Also, the measurement of reactive oxygen species and quantification of glutathione levels did not reveal any change mediated by SHOC2. The analysis of ERK1 / 2 activation has shown a discrete reduction in its expression. The results suggest that there may be some relationship between SHOC2 silencing, oxidative stress and survival, but there are other alternative pathways modulating this process which needs claryfication.